These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 7871570)

  • 1. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice.
    Exner BG; Que X; Mueller YM; Domenick MA; Neipp M; Ildstad ST
    Surgery; 1999 Aug; 126(2):121-6. PubMed ID: 10455873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
    Eto M; Yoshikai Y; Nishimura Y; Hiromatsu K; Maeda T; Nomoto K; Kong YY; Kubo RT; Kumazawa J; Nomoto K
    Immunology; 1994 Feb; 81(2):198-204. PubMed ID: 8157269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance.
    Wekerle T; Nikolic B; Pearson DA; Swenson KG; Sykes M
    Transpl Int; 2002 May; 15(5):248-53. PubMed ID: 12012046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.